期刊文献+

422份痰标本细菌培养及药敏试验分析 被引量:3

Sputum Culture and Sensitivity Analysis of 422 Cases
下载PDF
导出
摘要 目的分析痰液细菌培养的菌群分布及其耐药状况,为临床抗感染治疗提供参考依据。方法采用细菌培养鉴定及药敏试验板试验。结果422份痰标本分离到285株致病菌,包括12个属35种细菌,药敏结果显示:所有革兰阴性杆菌对亚胺培南敏感度最高,耐甲氧西林金黄色葡萄球菌仍对万古霉素高度敏感,真菌感染呈上升趋势,真菌对5-氟胞嘧啶、两性霉素B和制霉菌素高度敏感。结论痰液细菌培养及药敏试验对临床用药有非常重要的指导意义。 Objective To study and analyse the distribution and resistance training. Methods Ⅰ- dentification of bacterial culture and sensitivity test pilot plate were taken. Results 285 strains of bacteria were isolated from 422 sputum specimens, 35 types of bacteria, including 12 Bacterial genus . Susceptibility results were in Table (2,3,4). All Gram-negative bacilli is the highest sensitivity to impenem. Methicillin-resistant Staphylococcus aureus is still highly sensitive to vancomycin. Fungal infection upward trend. Fungi on 5-fluorocytosine, amphotericin B, nystatin are highly sensitive. Conclusion Sputum germicuhure and susceptibility test are important to clinical medication.
作者 王慧
出处 《河南职工医学院学报》 2007年第5期479-481,共3页 Journal of Henan Medical College For Staff and Workers
关键词 痰液细菌培养 菌群分布 药敏 sputum culture flora distribution susceptibility
  • 相关文献

参考文献4

二级参考文献33

  • 1侯晓娜,杨婧,万楠,刘珊,何莉,丁雪松,傅炜昕.1998~2004年临床分离病原菌的耐药性变迁[J].中国实验诊断学,2006,10(3):238-242. 被引量:7
  • 2[21]Takenouchi T, Sakagawa E, Sugawara M. Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones [J]. Antimicrob Agents Chemother, 1999,43(2): 406
  • 3[22]Masuda N, Sakagawa E, Ohya S. Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa[J]. Antiumicrob Agents Chemother , 1995,39(3) :645
  • 4[23]Lomovskaya O, Lee A, Hoshino K, et al. Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother,1999,43(6):1340
  • 5[24]Ziha-Zarifi Ⅰ, Llanes C, Kohler T, et al. In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-oprM [J]. Antimicrob Agents Chemother, 1999,43(2):287
  • 6[25]Lomovskaya O, Warren M S, Lee A, et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy[J].Antimicrob Agents Chemother, 2001,45(1):105
  • 7[1]Bush K, Jacoby G A, Medeiros A A. A functional classification scheme for β-lactanases and its correlation with molecular structure[J]. Artimicrob Agents Chemother , 1994,39(6): 1211
  • 8[2]Coulton S, Francois Ⅰ. β-Lactamases :targets for drug design [J].Prog Med Chem, 1994,31:298
  • 9[3]Nass T, Livermore D M,Nordmann P. Characterization of an LysR family potein, SemR from Serratia marcessecs S6. its effect on expression of the carbapenem-hydrolyzing β-lactamases Sme-1 and comparison of this regulator with other β-lactamases regulators[J]. Antimicrob Agents Chenother , 1995,39:629
  • 10[4]Rasmussen B A, Bush K, Keeney D, et al. Characterization of LMI-1β-lactamases, a nover class A carbapenem hydrolyzing enzyme from Enterobacter cloacae[J]. Antimicrob Agents Chemother, 1996,40:2080

共引文献53

同被引文献12

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部